Skip to main content
Fig. 4 | BMC Medical Research Methodology

Fig. 4

From: Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials

Fig. 4

5-year distant-recurrence free survival against the treatment-effect modifying score of the effect of trastuzumab in early breast cancer. Graphical representation of the model showed in Table 4. DRFS: distant-recurrence free survival, dot: point estimate, solid curves: average smoothed splines for point estimates, dashed curves: average smoothed splines for confidence bounds

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us